Brokerages Set Oscar Health, Inc. (NYSE:OSCR) PT at $22.93

Shares of Oscar Health, Inc. (NYSE:OSCR) have earned an average recommendation of “Moderate Buy” from the eight brokerages that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating, four have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $22.93.

Several brokerages have issued reports on OSCR. Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and dropped their target price for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. UBS Group started coverage on Oscar Health in a report on Monday, October 7th. They set a “neutral” rating and a $23.00 price objective for the company. Finally, Piper Sandler reiterated an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a research note on Tuesday, September 10th.

Insider Buying and Selling at Oscar Health

In other news, CFO Richard Scott Blackley sold 68,978 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $1,240,914.22. Following the completion of the sale, the chief financial officer now owns 884,213 shares of the company’s stock, valued at approximately $15,906,991.87. This represents a 7.24 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Vice Chairman Joshua Kushner acquired 276,040 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The shares were acquired at an average cost of $13.58 per share, for a total transaction of $3,748,623.20. Following the completion of the acquisition, the insider now owns 5,031,262 shares of the company’s stock, valued at $68,324,537.96. This trade represents a 5.80 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 1,055,478 shares of company stock valued at $14,432,852 and sold 194,569 shares valued at $3,433,319. 25.11% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Oscar Health

A number of hedge funds have recently made changes to their positions in OSCR. Sei Investments Co. boosted its position in Oscar Health by 100.0% during the first quarter. Sei Investments Co. now owns 42,998 shares of the company’s stock valued at $639,000 after purchasing an additional 21,497 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of Oscar Health by 2.4% during the first quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock valued at $216,846,000 after buying an additional 337,850 shares during the last quarter. American International Group Inc. boosted its holdings in shares of Oscar Health by 1.3% in the 1st quarter. American International Group Inc. now owns 79,411 shares of the company’s stock valued at $1,181,000 after buying an additional 1,009 shares in the last quarter. Quadrature Capital Ltd purchased a new position in shares of Oscar Health in the 1st quarter worth approximately $1,312,000. Finally, Price T Rowe Associates Inc. MD raised its stake in shares of Oscar Health by 153.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock worth $59,156,000 after acquiring an additional 2,409,160 shares in the last quarter. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Stock Up 5.5 %

Shares of OSCR opened at $16.86 on Friday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The business has a fifty day moving average of $17.80 and a 200 day moving average of $18.15. The company has a market cap of $4.17 billion, a PE ratio of -280.95 and a beta of 1.67. Oscar Health has a 52-week low of $7.29 and a 52-week high of $23.79.

Oscar Health (NYSE:OSCR) last released its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The firm had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. Oscar Health’s revenue was up 68.3% compared to the same quarter last year. During the same quarter last year, the business posted ($0.29) EPS. On average, sell-side analysts expect that Oscar Health will post -0.01 EPS for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.